The non-profit group, in collaboration with the Blue Buffalo Company and Pet Valu Canada, are set to award two individual grants of C$52,500 to researchers studying intestinal lymphoma in cats, as well as the early detection and/or prevention of cancer in dogs. The grant opportunities are limited to Canada-based researchers.
“Cancers continue to take the lives of too many of our dogs, and, the sooner we can detect these diseases early or even prevent them, the better,” says Morris Animal Foundation’s chief scientific officer, Janet Patterson-Kane, BVSc., PhD, FRCVS.
Indeed, cancer is the second most common cause of death for cats, the foundation reports, as well as a leading cause of death in dogs over the age of two.
“Intestinal lymphoma is a serious and common cancer affecting cats,” Dr. Patterson-Kane says. “We are grateful for the generous funding support from Blue Buffalo Company and Pet Valu, and for their long-term commitment to fighting pet cancer.”
Since 1962, Morris Animal Foundation has funded more than 300 cancer studies and invested nearly $40 million.
“Blue Buffalo was founded on a promise made to a lovable Airedale named Blue who struggled with cancer, a leading cause of death in pets,” says Blue Buffalo’s Canada national accounts manager, Denise DeVeer. “Delivering on that promise continues to be at the heart of what we do every day.”
“The team of animal care experts at Pet Valu are happy to raise awareness of and support this very meaningful cause, and we are so thankful to the devoted pet lovers who helped us support the fight against pet cancers” adds Pet Valu’s chief marketing and digital officer, Tanbir Grover.
Grant applications will be accepted until Dec. 14. Any researcher based in Canada is eligible to apply, and the projects must be conducted in Canada.
For more, click here.